GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oyster Point Pharma Inc (NAS:OYST) » Definitions » FFO per Share

Oyster Point Pharma (Oyster Point Pharma) FFO per Share


View and export this data going back to 2019. Start your Free Trial

What is Oyster Point Pharma FFO per Share?

FFO per Share only applies to REITs.

Oyster Point Pharma (Oyster Point Pharma) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oyster Point Pharma Inc (NAS:OYST) » Definitions » FFO per Share
Comparable Companies
STSA CLGN RZLT NXTC AXLA CTMX FNCH GLSI EVLO CRTX OCSE:NOVO B ASX:CSL REGN VRTX MRNA XKRX:207940 BNTX HKSE:02269 SGEN SZSE:300122
Traded in Other Exchanges
N/A
Address
202 Carnegie Center, Suite 109, Princeton, NJ, USA, 08540
Website
https://www.oysterpointrx.com
Oyster Point Pharma Inc is a biopharmaceutical company focused on the development of pharmaceutical therapies to treat ocular surface diseases. Its product candidate OC-01 is a nicotinic acetylcholine receptor (nAChR) agonist, is being developed as a nasal spray to treat the signs and symptoms of dry eye disease.
Executives
Ozawa Clare director ONE SANSOME STREET, SUITE 3630, SAN FRANCISCO CA 94104
Link William J Phd director, 10 percent owner ONE SANSOME STREET, SUITE 1650, SAN FRANCISCO CA 94104
Versant Venture Capital Vi, L.p. 10 percent owner ONE SANSOME STREET, SUITE 1650, SAN FRANCISCO CA 94104
Donald J Santel director 4362 24TH STREET, SAN FRANCISCO CA 94114
George Christopher Eliades director C/O OYSTER POINT PHARMA, INC., 202 CARNEGIE CENTER, SUITE 109, PRINCETON NJ 08540
Michael G Atieh director MERCK MEDCO MANAGED CARE INC, 100 SUMMIT AVE, MONTVALE NJ 07645
John Snisarenko officer: Chief Commercial Officer C/O ALIMERA SCIENCES, INC., 6120 WINDWARD PARKWAY, SUITE 290, ALPHARETTA GA 30005
Invopps Gp Iv, L.l.c. director, 10 percent owner 126 EAST 56TH STREET, 20THFLOOR, NEW YORK NY 10022
Vida Ventures, Llc 10 percent owner 40 BROAD STREET, SUITE 201, BOSTON MA 02109
Kkr Healthcare Strategic Growth Fund L.p. 10 percent owner C/O KOHLBERG KRAVIS ROBERTS & CO. L.P., 9 WEST 57TH STREET, SUITE 4200, NEW YORK NY 10019
Jeffrey Nau director, officer: President and CEO 202 CARNEGIE CENTER, SUITE 106, PRINCETON NJ 08540
Daniel Lochner officer: Chief Financial Officer 202 CARNEGIE CENTER, SUITE 106, PRINCETON NJ 08540
New Enterprise Associates 14, L.p. 10 percent owner 1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093
Kkr Group Partnership L.p. 10 percent owner C/O KOHLBERG KRAVIS ROBERTS & CO. L.P., 30 HUDSON YARDS, NEW YORK NY 10001
Invopps Iv Us, L.p. director, 10 percent owner 126 EAST 56TH STREET, 20TH FLOOR, NEW YORK NY 10022